todays sydney morning herald states that the announcement was more significant than the lukewarm response yesterday,analysts said.it substantially "derisks "ptd against the j+j issue.shipments to europe starting this month.sales of humira of u.s $250 million this year and peak at u.s$1 billion.for me this is a very low risk buying situation at these prices.
